Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Oct 23;9(11):ziaf152.
doi: 10.1093/jbmrpl/ziaf152. eCollection 2025 Nov.

Osteitis fibrosa cystica recovery following parathyroidectomy for primary hyperparathyroidism: a case series and review of literature

Affiliations
Review

Osteitis fibrosa cystica recovery following parathyroidectomy for primary hyperparathyroidism: a case series and review of literature

Yehudit Eden-Friedman et al. JBMR Plus. .

Abstract

Osteitis fibrosa cystica (OFC) is an extreme manifestation of accelerated bone resorption in primary hyperparathyroidism (PHPT), rarely encountered nowadays. Bone mineral density gain following parathyroidectomy (PTx) is well documented, while little is known regarding the timeline of lytic lesions remineralization and recovery. We present three patients with OFC, surgically treated for PHPT, with clinical, biochemical, and advanced radiological (CT or MRI) post-PTx follow-up. Additionally, we review published OFC case reports that include serial imaging of bony lesions following PTx. All patients received calcium, magnesium and alphacalcidiol supplementation post-PTx with serum calcium, PTH, and alkaline phosphatase gradually normalizing. Patients 1 and 2 exhibited an impressive remineralization of pelvic lytic lesions within 6 and 12 mo following PTx, respectively. Patient 3 showed partial remineralization of C4-C5 vertebrae at 6 mo, with continued improvement at 18 mo post-PTx. Both Patients 1 and 3 required salvage orthopedic intervention. We summarize reports of 54 patients with PHPT and OFC, assessed for lytic lesion recovery after PTx using various imaging modalities. Most lesions showed partial remineralization within 6-12 mo. Near full and complete remineralization was evident in 38 (70.3%) of the patients on the last imaging follow-up. Substantial remineralization of lytic lesions in OFC can be observed within months of PTx, even in large or symptomatic lesions. This early skeletal recovery may obviate the need for orthopedic intervention in selected patients and supports a conservative management approach when lesion location permits.

Keywords: hypercalcemia; lytic lesions; osteitis fibrosa cystica; parathyroidectomy; primary hyperparathyroidism; remineralization.

PubMed Disclaimer

Conflict of interest statement

None declared.

Figures

Graphical Abstract
Graphical Abstract
Figure 1
Figure 1
Computed tomography imaging of lytic bone lesions before and after parathyroidectomy in three patients with osteitis fibrosa cystica. (A and B) Case 1 (B: 6 mo post-PTx); (C and D) case 2 (D: 12 mo post-PTx); (E and F) case 3 (F: 5 mo post-PTx).
Figure 2
Figure 2
Flowchart of case report selection process. ESRD, end stage renal disease; OFC, osteitis fibrosa cystica; pHPT, primary hyperparathyroidism; PTx, parathyroidectomy.

References

    1. Bilezikian JP, Khan AA, Silverberg SJ, et al. Evaluation and management of primary hyperparathyroidism: summary statement and guidelines from the fifth international workshop. J Bone Miner Res. 2022;37(11):2293–2314. 10.1002/jbmr.4677 - DOI - PubMed
    1. Silverberg SJ, Bilezikian JP. Evaluation and management of primary hyperparathyroidism. J Clin Endocrinol Metab. 1996;81(6):2036–2040. 10.1210/jcem.81.6.8964825 - DOI - PubMed
    1. El-Hajj Fuleihan G, Chakhtoura M, Cipriani C, et al. Classical and nonclassical manifestations of primary hyperparathyroidism. J Bone Miner Res. 2022;37(11):2330–2350. 10.1002/jbmr.4679 - DOI - PubMed
    1. Roumpou A, Palermo A, Tournis S, et al. Bone in parathyroid diseases revisited: evidence from epidemiological, surgical and new drug outcomes. Endocr Rev. 2025;46(4):576–620. 10.1210/endrev/bnaf010 - DOI - PMC - PubMed
    1. Misiorowski W, Czajka-Oraniec I, Kochman M, Zgliczyński W, Bilezikian JP. Osteitis fibrosa cystica—a forgotten radiological feature of primary hyperparathyroidism. Endocrine. 2017;58(2):380–385. 10.1007/s12020-017-1414-2 - DOI - PMC - PubMed

LinkOut - more resources